11/25
01:58 pm
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
08:01 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
Low
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
11/25
07:05 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
Medium
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
11/18
06:27 am
uncy
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
Low
Report
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
11/12
08:19 am
uncy
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
Medium
Report
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
11/12
07:35 am
uncy
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
07:05 am
uncy
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
11/3
07:05 am
uncy
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Medium
Report
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
11/2
01:15 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) was upgraded by analysts at
Wall St
Medium
Report
Unicycive Therapeutics (NASDAQ:UNCY) was upgraded by analysts at
Wall St
11/2
01:15 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) was upgraded by analysts at
Wall St
Medium
Report
Unicycive Therapeutics (NASDAQ:UNCY) was upgraded by analysts at
Wall St
10/31
12:05 pm
uncy
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Low
Report
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
10/30
12:32 pm
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/30
07:05 am
uncy
Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference
Neutral
Report
Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference
10/29
08:02 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/28
07:05 am
uncy
Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
Medium
Report
Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
10/25
01:32 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) was downgraded by analysts at
Wall
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) was downgraded by analysts at
Wall
10/14
12:20 pm
uncy
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Low
Report
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
10/14
09:15 am
uncy
When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit? [Yahoo! Finance]
Low
Report
When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit? [Yahoo! Finance]
10/14
02:55 am
uncy
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
Low
Report
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
10/13
05:31 pm
uncy
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY
Medium
Report
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY
10/13
04:48 pm
uncy
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Medium
Report
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10/13
04:00 pm
uncy
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY
Low
Report
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY
10/13
03:41 pm
uncy
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors
Low
Report
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors
10/13
02:34 pm
uncy
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
Low
Report
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
10/13
12:23 pm
uncy
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
Low
Report
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics